These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2238957)
1. [The value of positron emission tomography in the diagnosis of recurrent rectal cancer]. Lehner B; Schlag P; Strauss L; Dimitrakopoulou A; Herfarth C Zentralbl Chir; 1990; 115(13):813-7. PubMed ID: 2238957 [TBL] [Abstract][Full Text] [Related]
2. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Ito K; Kato T; Tadokoro M; Ishiguchi T; Oshima M; Ishigaki T; Sakuma S Radiology; 1992 Feb; 182(2):549-52. PubMed ID: 1732979 [TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of the postoperative local recurrence of rectal cancer by FDG-PET--a case report]. Katsumoto Y; Maruyama N; Nakamura M; Shingai T; Maruyama K; Nakaguchi K; Furukawa J; Okajima S; Sue F; Fukunaga H; Ikenaga M; Sekimoto K Gan To Kagaku Ryoho; 2001 Oct; 28(11):1688-91. PubMed ID: 11708010 [TBL] [Abstract][Full Text] [Related]
4. Scar or recurrent rectal cancer. Positron emission tomography is more helpful for diagnosis than immunoscintigraphy. Schlag P; Lehner B; Strauss LG; Georgi P; Herfarth C Arch Surg; 1989 Feb; 124(2):197-200. PubMed ID: 2783844 [TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT in the detection of recurrent rectal cancer. Kau T; Reinprecht P; Eicher W; Lind P; Starlinger M; Hausegger KA Int Surg; 2009; 94(4):315-24. PubMed ID: 20302028 [TBL] [Abstract][Full Text] [Related]
6. Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity. Ito K; Kato T; Ohta T; Tadokoro M; Yamada T; Ikeda M; Nishino M; Ishigaki T; Gambhir S Eur J Nucl Med; 1996 Oct; 23(10):1372-7. PubMed ID: 8781143 [TBL] [Abstract][Full Text] [Related]
7. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Even-Sapir E; Parag Y; Lerman H; Gutman M; Levine C; Rabau M; Figer A; Metser U Radiology; 2004 Sep; 232(3):815-22. PubMed ID: 15273334 [TBL] [Abstract][Full Text] [Related]
8. Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging. Keogan MT; Lowe VJ; Baker ME; McDermott VG; Lyerly HK; Coleman RE Abdom Imaging; 1997; 22(3):332-7. PubMed ID: 9107663 [TBL] [Abstract][Full Text] [Related]
9. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer. Chessin DB; Kiran RP; Akhurst T; Guillem JG J Am Coll Surg; 2005 Dec; 201(6):948-56. PubMed ID: 16310700 [No Abstract] [Full Text] [Related]
10. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536 [TBL] [Abstract][Full Text] [Related]
11. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Hofer C; Laubenbacher C; Block T; Breul J; Hartung R; Schwaiger M Eur Urol; 1999; 36(1):31-5. PubMed ID: 10364652 [TBL] [Abstract][Full Text] [Related]
12. PET scans of abdominal malignancy. Blahd WH; Brown CV; Khonsary SA; Farahi JB; Quinones N; Ribe JY; Coyle JJ; Glass EC; Mandelkern MA World J Surg; 1996 Feb; 20(2):245-7. PubMed ID: 8661826 [TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of fusion images using (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography in local recurrence of rectal cancer. Fukunaga H; Sekimoto M; Tatsumi M; Ikenaga M; Ohue M; Seshimo I; Higuchi I; Takayama O; Yasui M; Ikeda M; Yamamoto H; Monden M Int J Oncol; 2002 Apr; 20(4):691-5. PubMed ID: 11894111 [TBL] [Abstract][Full Text] [Related]
14. [Value of positron emission tomography (18F-FDG-PET) in the diagnosis of recurrent rectal cancer]. Franke J; Rosenzweig S; Reinartz P; Höer J; Kasperk R; Schumpelick V Chirurg; 2000 Jan; 71(1):80-5. PubMed ID: 10663007 [TBL] [Abstract][Full Text] [Related]
15. The value of computed tomography in the diagnostics of recurrent rectal tumors. Rotte KH; Hebbar HG; Ghoneim IM Arch Geschwulstforsch; 1988; 58(3):185-90. PubMed ID: 3415436 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET. Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747 [TBL] [Abstract][Full Text] [Related]
17. [Imaging modalities in the assessment of presacral recurrent rectal cancer]. Wang Y; Yang S Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):456-460. PubMed ID: 32842424 [TBL] [Abstract][Full Text] [Related]
18. [Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose]. Römer W; Avril N; Dose J; Ziegler S; Kuhn W; Herz M; Jänicke F; Schwaiger M Rofo; 1997 Jan; 166(1):62-8. PubMed ID: 9072107 [TBL] [Abstract][Full Text] [Related]
19. The appearances on computed tomography after abdominoperineal resection for carcinoma of the rectum: a comparison between the normal appearances and those of recurrence. Reznek RH; White FE; Young JW; Fry IK; Nicholls RJ Br J Radiol; 1983 Apr; 56(664):237-40. PubMed ID: 6831146 [TBL] [Abstract][Full Text] [Related]
20. [A case of curative resection of local recurrence after abdominosacral resection of recurrent rectal cancer based on the diagnosis of PET/CT fusion images]. Ohue M; Sekimoto M; Fukunaga H; Ikenaga M; Yamamoto H; Ikeda M; Yasui M; Takayama H; Hata Y; Kitani K; Seki Y; Hujie Y; Higuchi I; Monden M Gan To Kagaku Ryoho; 2003 Oct; 30(11):1829-32. PubMed ID: 14619531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]